![Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01775-6/MediaObjects/41591_2022_1775_Fig1_HTML.png)
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition | Nature Medicine
![CORRECTING and REPLACING Alliance for Clinical Trials in Oncology and Pfizer Receive the CEO Roundtable on Cancer's Dr. Charles A. Sanders Life Sciences Awards | Business Wire CORRECTING and REPLACING Alliance for Clinical Trials in Oncology and Pfizer Receive the CEO Roundtable on Cancer's Dr. Charles A. Sanders Life Sciences Awards | Business Wire](https://mms.businesswire.com/media/20151211005395/en/500441/5/CEORT-PR-121015-Charlie-Group-Photo.jpg)
CORRECTING and REPLACING Alliance for Clinical Trials in Oncology and Pfizer Receive the CEO Roundtable on Cancer's Dr. Charles A. Sanders Life Sciences Awards | Business Wire
![Alliance for Clinical Trials in Oncology on X: "For #TrialTuesday, .@xiaoweimd @DanaFarber leads @ALLIANCE_org A031901 that compares survival in patients w/#urothelialcancer who stop #immunecheckpoint inhibitor treatment after about year to patients who Alliance for Clinical Trials in Oncology on X: "For #TrialTuesday, .@xiaoweimd @DanaFarber leads @ALLIANCE_org A031901 that compares survival in patients w/#urothelialcancer who stop #immunecheckpoint inhibitor treatment after about year to patients who](https://pbs.twimg.com/media/FEVWymqXIAE-tDv.jpg)
Alliance for Clinical Trials in Oncology on X: "For #TrialTuesday, .@xiaoweimd @DanaFarber leads @ALLIANCE_org A031901 that compares survival in patients w/#urothelialcancer who stop #immunecheckpoint inhibitor treatment after about year to patients who
![Alliance for Clinical Trials in Oncology on Twitter: "Happy #TrialTuesday! Let's take a closer look at Alliance trial N0577, led by Dr. Kurt A. Jaeckle, @AtlanticHealth! The CODEL trial is a phase Alliance for Clinical Trials in Oncology on Twitter: "Happy #TrialTuesday! Let's take a closer look at Alliance trial N0577, led by Dr. Kurt A. Jaeckle, @AtlanticHealth! The CODEL trial is a phase](https://pbs.twimg.com/media/DeXpzcRWAAYLfYo.jpg)
Alliance for Clinical Trials in Oncology on Twitter: "Happy #TrialTuesday! Let's take a closer look at Alliance trial N0577, led by Dr. Kurt A. Jaeckle, @AtlanticHealth! The CODEL trial is a phase
![Custom T-Shirts for Alliance For Clinical Trials In Oncology Chicago Office Group Photo - Shirt Design Ideas Custom T-Shirts for Alliance For Clinical Trials In Oncology Chicago Office Group Photo - Shirt Design Ideas](https://s3.amazonaws.com/customink-iotw-east-prod/images/84925/original/IMG_2809.jpg?1518470350)
Custom T-Shirts for Alliance For Clinical Trials In Oncology Chicago Office Group Photo - Shirt Design Ideas
![Alliance for Clinical Trials in Oncology on Twitter: "New Trial! For #TrialTuesday, Gopakumar Iyer, MD, @sloan_kettering, leads a trial (A031701) on how well gemcitabine hydrochloride and cisplatin work in treating patients with Alliance for Clinical Trials in Oncology on Twitter: "New Trial! For #TrialTuesday, Gopakumar Iyer, MD, @sloan_kettering, leads a trial (A031701) on how well gemcitabine hydrochloride and cisplatin work in treating patients with](https://pbs.twimg.com/media/Dm0RtzwUYAAb1Q3.jpg)
Alliance for Clinical Trials in Oncology on Twitter: "New Trial! For #TrialTuesday, Gopakumar Iyer, MD, @sloan_kettering, leads a trial (A031701) on how well gemcitabine hydrochloride and cisplatin work in treating patients with
![Alliance for Clinical Trials in Oncology on Twitter: "The POSITIVE trial, led by Ann Partridge MD MPH, of Dana-Farber, looks at pregnancy outcome and safety of interrupting therapy for women with endocrine Alliance for Clinical Trials in Oncology on Twitter: "The POSITIVE trial, led by Ann Partridge MD MPH, of Dana-Farber, looks at pregnancy outcome and safety of interrupting therapy for women with endocrine](https://pbs.twimg.com/media/DwUMBxsWkAAraGs.jpg)
Alliance for Clinical Trials in Oncology on Twitter: "The POSITIVE trial, led by Ann Partridge MD MPH, of Dana-Farber, looks at pregnancy outcome and safety of interrupting therapy for women with endocrine
![Interview with Patty Spears, Patient Advocate at the Alliance for Clinical Trials in Oncology - Xtalks Interview with Patty Spears, Patient Advocate at the Alliance for Clinical Trials in Oncology - Xtalks](https://i0.wp.com/xtalks.com/wp-content/uploads/2022/10/844A9838-Patty-Spears-scaled.jpg?fit=2560%2C1708&ssl=1)